"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

Number of inclusions @ 6 May 2020

1901!                               More >>

Publication success

We are excited to announce the acceptance/publication of three IGOS-related papers
  1. Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomized ISID study, Verboon, et al, Journal of Neurology, Neurosurgery, and Psychiatry
  2. Current treatment practice of Guillain-Barré syndrome, Verboon, et al, Neurology
  3. Diagnosis and management of Guillain–Barré syndrome in ten steps, Leonhard et al, Nature Reviews Neurology
More >>
More news

International Guillain-Barré syndrome outcome study (IGOS)



Welcome to the website for the International Guillain-Barré syndrome Outcome Study (IGOS). The study aims to identify clinical and biological determinants and predictors of disease course in Guillain-Barré syndrome. The study is conducted by the Inflammatory Neuropathy Consortium (INC). At this website you can acquire information about IGOS, register as IGOS participant and include patients with Guillain-Barré syndrome. For more information about IGOS, click here.